Less Ads, More Data, More Tools Register for FREE

UPDATE 1-Second vaccine clears path out of pandemic by Spring - UK's Hancock

Wed, 30th Dec 2020 07:36

(Adds quotes)

LONDON, Dec 30 (Reuters) - The Oxford University-AstraZeneca
COVID-19 vaccine approved by Britain on Wednesday provides a
path out of the pandemic by the spring, by which time millions
of vulnerable people will be protected, Health Secretary Matt
Hancock said.

"The NHS will be able to deliver these shots into people's
arms at the speed at which it can be manufactured," he told Sky
News.

"I am also now, with this approval this morning, highly
confident that we can get enough vulnerable people vaccinated by
the spring that we can now see our route out of this pandemic."

He said the recommended 12-week gap between the first and
second doses of the Oxford-AstraZeneca shot was "very helpful"
because it enabled more people to be immunized with a first shot
that offered a high level of protection on its own.

(Reporting by Paul Sandle; editing by Guy Faulconbridge)

Related Shares

More News
30 May 2024 09:23

LONDON BROKER RATINGS: Jefferies and UBS cut Anglo American

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Wednesday:

30 May 2024 07:40

LONDON BRIEFING: Dr Martens cuts payout as profit plummets

(Alliance News) - Stocks in London are called to open lower on Thursday, with investors nervous ahead of Friday's US inflation print.

29 May 2024 08:54

IN BRIEF: AstraZeneca drug lowers cholesterol in phase 1 trial

AstraZeneca PLC - Cambridge, England-based pharmaceuticals - Reports positive results in a phase 1 trial of cholesterol drug candidate AZD0780, an ora...

28 May 2024 07:02

AstraZeneca experimental lung cancer drug shows promising results

(Sharecast News) - AstraZeneca's experimental lung cancer drug showed improved overall survival rates in phase III trials, the pharmaceutical giant sa...

27 May 2024 07:49

IN BRIEF: Astra, Daiichi hail positive survival data for Dato-DXd

AstraZeneca PLC - Cambridge, UK-based pharmaceutical firm - Alongside Japan's Daiichi Sankyo Co Ltd, notes positive data for datopotamab deruxtecan in...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.